These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30252633)

  • 1. Association of Serum Vitamin D Concentration With Clinical Symptoms and Quality of Life in Patients With Irritable Bowel Syndrome.
    Abbasnezhad A; Amani R; Hasanvand A; Yousefi Rad E; Alipour M; Saboori S; Choghakhori R
    J Am Coll Nutr; 2019; 38(4):327-333. PubMed ID: 30252633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
    Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of life.
    Choghakhori R; Abbasnezhad A; Hasanvand A; Amani R
    Cytokine; 2017 May; 93():34-43. PubMed ID: 28506572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R; Abbasnezhad A; Amani R; Alipour M
    Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial.
    Khalighi Sikaroudi M; Mokhtare M; Janani L; Faghihi Kashani AH; Masoodi M; Agah S; Abbaspour N; Dehnad A; Shidfar F
    Complement Med Res; 2020; 27(5):302-309. PubMed ID: 32203968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status in pediatric irritable bowel syndrome.
    Nwosu BU; Maranda L; Candela N
    PLoS One; 2017; 12(2):e0172183. PubMed ID: 28192499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.
    Roth B; Ohlsson B
    BMC Gastroenterol; 2024 Sep; 24(1):296. PubMed ID: 39227769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?
    Williams CE; Williams EA; Corfe BM
    Eur J Clin Nutr; 2018 Oct; 72(10):1358-1363. PubMed ID: 29367731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Role of Vitamin D and the Gut Microbiome: A Cross-Sectional Study of Individuals with Irritable Bowel Syndrome and Healthy Controls.
    Matthews SW; Plantinga A; Burr R; Cain KC; Savidge T; Kamp K; Heitkemper MM
    Biol Res Nurs; 2023 Jul; 25(3):436-443. PubMed ID: 36624571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Transaminase Concentrations and the Presence of Irritable Bowel Syndrome Are Associated with Serum 25-Hydroxy Vitamin D Concentrations in Adolescent Girls Who Are Overweight and Obese.
    Khayyatzadeh SS; Vatanparast H; Avan A; Bagherniya M; Bahrami A; Kiani MA; Bahrami-Taghanaki H; Ferns GA; Ghayour-Mobarhan M
    Ann Nutr Metab; 2017; 71(3-4):234-241. PubMed ID: 29136622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial.
    Khalighi Sikaroudi M; Mokhtare M; Shidfar F; Janani L; Faghihi Kashani A; Masoodi M; Agah S; Dehnad A; Shidfar S
    EXCLI J; 2020; 19():652-667. PubMed ID: 33013260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Chemerin, Apelin, and Adiponectin in Relation to Clinical Symptoms, Quality of Life, and Psychological Factors in Irritable Bowel Syndrome.
    Baram MA; Abbasnezhad A; Ghanadi K; Anbari K; Choghakhori R; Ahmadvand H
    J Clin Gastroenterol; 2020; 54(5):e40-e49. PubMed ID: 31306342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
    Patel A; Hasak S; Cassell B; Ciorba MA; Vivio EE; Kumar M; Gyawali CP; Sayuk GS
    Aliment Pharmacol Ther; 2016 Aug; 44(3):246-58. PubMed ID: 27240555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial.
    El Amrousy D; Hassan S; El Ashry H; Yousef M; Hodeib H
    Saudi J Gastroenterol; 2018; 24(2):109-114. PubMed ID: 29637918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: a systematic review and meta-analysis.
    Bin Y; Kang L; Lili Y
    Nutr Hosp; 2022 Oct; 39(5):1144-1152. PubMed ID: 35546472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
    Hod K; Sperber AD; Maharshak N; Ron Y; Shapira I; David Z; Rogowski O; Berliner S; Shenhar-Tsarfaty S; Dekel R
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13464. PubMed ID: 30240124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
    Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
    J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.